Hologic completes $230M acquisition of California cancer test company wbjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wbjournal.com Daily Mail and Mail on Sunday newspapers.
By Sam Bonacci
Hologic is continuing its acquisition spree with an agreement to purchase San Diego cancer test firm Biotheranostics for $230 million, the Marlborough company announced late on Monday.
The acquisition is the third for the medical device manufacturer in the last five months and the largest financial outlay of all the transactions. Early on Monday, the company announced the $64 million purchase of biopsy firm SOMATEX Medical Technologies GmbH, based in the German capital of Berlin, with the aim of expanding its European presence. In August, Hologic announced a roughly $80-million acquisition of Texas-based Acessa Health with a minimally invasive treatment alternative to hysterectomies and myomectomies, according to Hologic.